DTwP-HepB-Hib vaccine: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 28: | Line 28: | ||
{{Vaccine-stub}} | {{Vaccine-stub}} | ||
{{Pharmacology-stub}} | {{Pharmacology-stub}} | ||
<gallery> | |||
File:Prequalified_pentavalent_and_years_of_sales_to_UNICEF._Figure_5.jpg|Prequalified pentavalent and years of sales to UNICEF | |||
File:Pentavalent_per-dose_price_ranges,_to_UNICEF,_2005–2019._Figure_7.jpg|Pentavalent per-dose price ranges to UNICEF, 2005–2019 | |||
</gallery> | |||
Latest revision as of 01:05, 18 February 2025
DTwP-HepB-Hib vaccine is a combination vaccine used to protect against diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type b (Hib). This vaccine is a part of the World Health Organization's Expanded Program on Immunization (EPI) and is recommended for use in all countries.
Composition[edit]
The DTwP-HepB-Hib vaccine contains five different components:
- Diphtheria toxoid (DT): This is a modified form of the toxin produced by the bacterium Corynebacterium diphtheriae. The toxoid stimulates the immune system to produce antibodies against the diphtheria toxin.
- Tetanus toxoid (TT): This is a modified form of the toxin produced by the bacterium Clostridium tetani. The toxoid stimulates the immune system to produce antibodies against the tetanus toxin.
- Whole-cell pertussis vaccine (wP): This is a vaccine made from killed Bordetella pertussis bacteria, which cause whooping cough.
- Hepatitis B vaccine (HepB): This vaccine contains a protein from the surface of the hepatitis B virus, which stimulates the immune system to produce antibodies against the virus.
- Hib vaccine: This vaccine contains a part of the Haemophilus influenzae type b bacterium, which stimulates the immune system to produce antibodies against the bacterium.
Administration[edit]
The DTwP-HepB-Hib vaccine is usually given as a series of three injections, at 6, 10, and 14 weeks of age. The vaccine is injected into the muscle of the thigh or upper arm.
Effectiveness[edit]
The DTwP-HepB-Hib vaccine is highly effective at preventing the diseases it targets. It provides long-lasting immunity and is considered safe for use in infants and young children.
Side effects[edit]
Like all vaccines, the DTwP-HepB-Hib vaccine can cause side effects, although they are generally mild and temporary. Common side effects include pain and swelling at the injection site, fever, and irritability.
See also[edit]
-
Prequalified pentavalent and years of sales to UNICEF
-
Pentavalent per-dose price ranges to UNICEF, 2005–2019

